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Health literacy is not only the degree to which individuals can obtain and understand 
basic health information, but also 
includes their ability to act on that 
information to make informed health 
decisions (1). Lower levels of health 
literacy, and in particular reading 
ability, have been associated with a 
high prevalence of adverse health 
outcomes because of an inadequate 
use of health care services (2–6). In 
the context of type 2 diabetes, the 
impact of health literacy on health 
outcomes is not fully understood. 
The American Diabetes Association 
(ADA) continues to recommend that 
physicians prescribe self-monitoring 
of blood glucose (SMBG) to patients 
with noninsulin-treated type 2 diabe-
tes, because SMBG is associated with 
meeting A1C targets (7,8). However, 
for SMBG to be useful, the ADA rec-
ommends integrating glucose values 
into clinical and self-management 
plans (8). Our study aimed to explore 
the association between patient health 
literacy and patient-reported out-
comes such as numeracy of SMBG 
use, how often physicians advised 
patients to conduct SMBG testing, 
and the clinical outcome of glycemic 
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Objective. To measure the association between health literacy and both 
patient-reported and clinical outcomes in patients with non–insulin-treated 
type 2 diabetes.
Research Design and Methods. We surveyed patients with non–insulin- 
treated type 2 diabetes (n = 448) from 15 primary care practices. The asso-
ciation between health literacy and patient-reported and clinical outcomes, 
including numeracy of self-monitoring of blood glucose (SMBG) use, how 
often physicians advised patients to conduct SMBG testing, and glycemic 
control (as measured by A1C), was investigated.
Results. Study participants included 448 patients with non–insulin-treated 
type 2 diabetes located within central North Carolina. Participants with lim-
ited health literacy had poorer glycemic control (A1C 7.7 ± 1.1% vs. 7.5 ± 
1.0%, P = 0.016) despite using SMBG testing more frequently (daily SMBG 
testing 49.3 vs. 30.7%, P = 0.001) compared to individuals with adequate 
health literacy. The difference in how often physicians advised patients to 
conduct SMBG testing between limited and adequate health literacy groups 
was not significant (P = 0.68).
Conclusion. Limited health literacy was associated with poorer glyce-
mic control and an increased frequency of SMBG testing in patients with 
non–insulin-treated type 2 diabetes. There was no significant difference in 
how often physicians advised patients to conduct SMBG testing between 
patients with limited and adequate health literacy.
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control as measured by A1C in pa-
tients with noninsulin-treated type 2 
diabetes.
Research Design and Methods
Participants and Measures
This study used baseline data ob-
tained from a parent study investigat-
ing whether SMBG testing in patients 
with noninsulin-treated type 2 diabe-
tes and varying baseline characteris-
tics led to improvements in patient- 
reported and clinical outcomes over 
time (9). In the parent study, there 
was no significant difference in gly-
cemic control at 1 year between 
patients who performed once-daily 
SMBG and those who did not per-
form SMBG. Given the results, we 
examined the role of patient health 
literacy in overall glycemic control 
and SMBG usage (9). Our study pop-
ulation included 448 patients with 
noninsulin-treated type 2 diabetes 
who attended one of 15 University 
of North Carolina Health Care– 
associated primary care practices 
(family and internal medicine) lo-
cated within central North Carolina. 
Eligible patients were ≥30 years of age 
and had an A1C level between 6.5 
and 9.5% within 6 months preceding 
enrollment. Patients were excluded if 
they planned to see an endocrinolo-
gist within the next 12 months or if 
they planned to use insulin during 
the study period. The Newest Vital 
Sign (NVS) screening tool was used 
to assess health literacy in our patient 
population instead of other tradition-
al tools for measuring health literacy. 
The NVS is easily administered in 3 
minutes and is a research tool that 
uses a patient’s ability to read and 
analyze a nutritional label to test 
prose literacy, numeracy, and docu-
ment literacy (10). The NVS scores 
range from 0 to 6, with higher scores 
(≥4) associated with adequate health 
literacy (11). At baseline, all study 
participants were asked whether they 
currently use SMBG. If SMBG was 
used, participants indicated both how 
often they tested and how often they 
were told to test by their personal pri-
mary care physician. A1C levels were 
measured using venous blood draws 
and standard laboratory processing 
procedures.
Data Collection
Demographic, socioeconomic, and 
clinical characteristics were collected 
from baseline interviews with each 
patient.
Statistical Analysis
Data analysis was conducted on all 
448 participants who had completed 
all baseline assessments. Wilcoxon 
rank sum and χ2 tests were used to 
assess the mean difference in gly-
cemic control, patient-reported 
frequency of SMBG testing, and how 
often physicians advised patients to 
conduct SMBG testing between 
patients with limited and adequate 
health literacy. NVS scores were di-
chotomized using the previously re-
ported cutoff point of 4 to determine 
patient health literacy (≥4 indicates 
adequate health literacy) (7).
Results
Table 1 summarizes the demograph-
ic, socioeconomic, and clinical data 
obtained from each participant. 
Participants were relatively well- 
educated individuals, mostly married, 
and the majority female (54.0%), 
with an average age of 60.5 years. 
The mean A1C level of all respon-
dents was 7.6% (±1.1%). A total 
of 38.2% of participants was deter-
mined to have limited health litera-
cy. Participants with limited health 
literacy had significantly poorer gly-
cemic control than participants with 
adequate health literacy (A1C 7.7 ± 
1.1% vs. 7.5 ± 1.0%, P = 0.016).
Table 2 illustrates the frequency of 
SMBG testing completed by patients 
and how often patients were told to 
test by their physicians. The results 
are labeled as once daily, intermit-
tently (not daily, but one or more 
times per week), and rarely (less than 
one time per week). Of the partici-
pants who were currently performing 
SMBG testing (n = 336), 55.7% had 
been told by their physicians to per-
form once-daily SMBG testing. 
There was no statistically significant 
difference in the frequency of which 
physicians told their patients to con-
duct SMBG testing between limited 
and adequate health literacy groups 
(P = 0.68) (Table 2). Of the partici-
pants who did not partake in SMBG 
testing (n = 112), 44.6% reported not 
doing so because they had not been 
advised by their physicians to test; 
and 16.1, 7.1, and 6.25% did not do 
so because of cost, pain associated 
with testing, and not understanding 
the benefits of testing, respectively.
Significantly more patients with 
limited health literacy performed 
once-daily SMBG testing signifi-
cantly (once-daily SMBG testing 
49.3 vs. 30.7%, P = 0.001) compared 
to individuals with adequate health 
literacy (Table 2).
Conclusion
Despite prior research indicating 
the unclear usefulness and cost- 
effectiveness of SMBG in patients 
with noninsulin-treated type 2 di-
abetes, this study illustrates that 
a majority (55.7%) of physicians 
who advise their patients to under-
go SMBG testing advise them to test 
once daily. Despite most patients 
receiving the recommendation to 
conduct once-daily SMBG testing, 
29.45% of patients who were not cur-
rently testing did not do so because 
of the cost of testing materials, the 
pain associated with testing, or their 
lack of understanding regarding the 
benefits of testing. This result aligns 
with research that indicates SMBG 
being useful and cost-effective only 
in patients who can incorporate their 
SMBG values in their diabetes care 
plan and treatment goals (12).
There was no significant difference 
in how often patients with noninsulin- 
treated type 2 diabetes and limited 
or adequate health literacy were told 
by their physicians to conduct SMBG 
testing. Regardless of each patient’s 
health literacy status, the majority of 
physicians advised their patients to 
perform once-daily SMBG testing. 
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The need for individualized diabetes 
treatment plans has previously been 
called into question by research that 
determined that personal blood glu-
cose testing patterns were frequently 
omitted by physicians and that many 
patients experience difficulty under-
taking lifestyle changes (i.e., diet 
and exercise) based on the results of 
their regular SMBG testing (13). This 
study adds to the discussion regard-
ing whether more individualized 
treatment plans can be used to aid 
patients in achieving better glycemic 
control and a higher quality of life.
There were several limitations 
to our study and data analysis. 
One-on-one patient interviews and 
TABLE 1. Summary of Demographic and Clinical Data for All Participants With Limited Versus 
Adequate Health Literacy (n = 448)
Characteristic Health Literacy
Limited* (n = 171) Adequate (n = 277)
Age, years, mean (min, max) 64.3 (31, 92) 58.1 (32, 85)
Male, n (%) 86 (50.3) 121 (43.7)
Race, n (%)
White









Less than high school
High school graduate/some college














Number of comorbidities, mean (min, max) 3.7 (0, 10) 3.2 (0, 8)
Type 2 diabetes duration, years, mean (min, max) 9.2 (0, 44) 7.6 (0, 50)
BMI, kg/m2, mean (min, max) 32.8 (21, 57) 35.2 (21, 75)
A1C, %, mean (min, max) 7.7 (6, 13) 7.5 (6, 13)







*Limited health literacy defined as <4 on NVS assessment tool.
TABLE 2. Comparison of Physician-Advised and Self-Reported SMBG Use in Patients With Limited 
Versus Adequate Health Literacy in Individuals Currently Using SMBG Testing (n = 336)
Outcome Health Literacy
Limited (n = 134),  
n (%)
Adequate (n = 202),  
n (%)
P
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questionnaires were used to obtain 
patient-reported outcomes, including 
frequency of SMBG testing and how 
often physicians told their patients 
to conduct SMBG testing. Medical 
records were not used to determine 
the frequency of SMBG testing 
assigned by each patient’s physician, 
which introduces the potential for 
recall bias. Furthermore, the reasons 
for increased frequency of SMBG 
testing in patients with limited health 
literacy were not examined in this 
study.
In the context of patient A1C 
levels, our study adds to previous 
research that has found a decreased 
level of glycemic control in patients 
with limited health literacy (14,15). 
Patients with limited health literacy 
have a decreased degree of glycemic 
control despite using SMBG testing 
significantly more often than indi-
viduals with adequate health literacy. 
This finding is paradoxical because 
numeracy of SMBG use is a measure 
of diabetes self-care, which is gener-
ally associated with better glycemic 
control. A decreased level of glycemic 
control despite using SMBG testing 
more often in patients with limited 
health literacy demonstrates the need 
for more rigorous patient education 
to ensure patients understand the 
true benefit of using SMBG testing 
and what can be done to manipu-
late their obtained blood glucose 
levels. In addition, avoiding unnec-
essary SMBG testing can reduce the 
pain and costs involved with routine 
SMBG testing, therefore minimizing 
the barriers involved with proper test-
ing at times of necessity.
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